<DOC>
	<DOCNO>NCT00169442</DOCNO>
	<brief_summary>To assess immune memory follow primary vaccination DTPw-HBV/Hib vaccine ass immunogenicity reactogenicity booster dose give 15 - 18 month age .</brief_summary>
	<brief_title>Immune Memory DTPw-HBV/Hib Vaccine Following Primary Vaccination , Immuno &amp; Reacto Booster Dose Given Infants</brief_title>
	<detailed_description>- Subjects receive DTPw-HBV/Hib primary vaccination without HBV birth randomise ( 1:3 ratio ) receive either : Plain PRP 10 month age follow DTPw-HBV 15-18 month age DTPw-HBV/Hib 15-18 month age . - Subjects receive DTPw-HBV + Hib primary vaccination without HBV birth receive DTPw-HBV + Hib booster . - Subjects receive DTPw-HBV/Hib primary vaccination HBV birth receive DTPw-HBV/Hib vaccine booster .</detailed_description>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Diphtheria</mesh_term>
	<criteria>Inclusion criterion : For subject receive Plain PRP follow DTPwHBV : Male female infant , 10 11 month age , previously complete threedose primary vaccination course DTPwHBV/Hib vaccine . For subject receive DTPwHBV/Hib DTPwHBV + Hib : Male female infant , 1518 month age , previously complete threedose primary vaccination course DTPwHBV/Hib vaccine . For subject : Subjects investigator believe parent/guardian comply requirement protocol . Free obvious health problem establish medical history clinical examination Exclusion criterion : Use investigational nonregistered product study vaccine ( ) within 30 day precede administration study vaccine , plan use study period . Chronic administration immunosuppressant immunemodifying drug within six month prior administration study vaccine . Planned administration/administration vaccine foreseen study protocol start 30 day end 30 day administration study vaccine exception oral polio vaccine .</criteria>
	<gender>All</gender>
	<minimum_age>10 Months</minimum_age>
	<maximum_age>18 Months</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>